LPL Financial’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Buy |
14,685
+700
| +5% | +$1.58K | ﹤0.01% | 5264 |
|
|
2025
Q1 | $29.9K | Sell |
13,985
-3,446
| -20% | -$7.37K | ﹤0.01% | 5079 |
|
|
2024
Q4 | $42.2K | Sell |
17,431
-21,250
| -55% | -$51.4K | ﹤0.01% | 4996 |
|
|
2024
Q3 | $94.4K | Sell |
38,681
-1,790
| -4% | -$4.37K | ﹤0.01% | 4799 |
|
|
2024
Q2 | $104K | Sell |
40,471
-5,130
| -11% | -$13.2K | ﹤0.01% | 4635 |
|
|
2024
Q1 | $133K | Buy |
45,601
+2,435
| +6% | +$7.11K | ﹤0.01% | 4539 |
|
|
2023
Q4 | $99.7K | Buy |
43,166
+5,950
| +16% | +$13.7K | ﹤0.01% | 4487 |
|
|
2023
Q3 | $97.1K | Buy |
37,216
+21,000
| +130% | +$54.8K | ﹤0.01% | 4369 |
|
|
2023
Q2 | $58.1K | Buy |
+16,216
| New | +$58.1K | ﹤0.01% | 4354 |
|
|
2021
Q1 | – | Sell |
-14,135
| Closed | -$60K | – | 4105 |
|
|
2020
Q4 | $60K | Buy |
+14,135
| New | +$60K | ﹤0.01% | 3702 |
|